​

Pulse Biosciences (PLSE) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PLSE Stock Rating

Pulse Biosciences stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (50.00%), 2 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 2 2 Strong Sell Sell Hold Buy Strong Buy

PLSE Price Target Upside V Benchmarks

TypeNameUpside
StockPulse Biosciences-
SectorHealthcare Stocks 19.91%
IndustryMedical Instruments & Supplies Stocks23.19%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$14.71$14.71$14.71
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 25-1---1
Nov, 24--1--1
Oct, 24--1--1
Sep, 24--1--1
Aug, 24--1--1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-2.26$-1.74$-0.88---
Avg Forecast$-2.27$-1.75$-0.96$-0.95$-0.60$-0.47
High Forecast$-2.27$-1.75$-0.96$-0.95$-0.60$-0.47
Low Forecast$-2.27$-1.75$-0.96$-0.95$-0.60$-0.47
Surprise %-0.44%-0.57%-8.33%---

Revenue Forecast

$0 $7M $14M $21M $28M $35M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$1.42M$700.00K----
Avg Forecast$1.45M$709.00K-$800.00K$23.37M$34.47M
High Forecast$1.45M$709.00K-$800.00K$23.37M$34.47M
Low Forecast$1.45M$709.00K-$800.00K$23.37M$34.47M
Surprise %-1.94%-1.27%----

Net Income Forecast

$-110M $-92M $-74M $-56M $-38M $-20M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-63.16M$-58.95M$-42.21M---
Avg Forecast$-109.05M$-84.07M$-46.12M$-45.64M$-28.82M$-22.58M
High Forecast$-109.05M$-84.07M$-46.12M$-45.64M$-28.82M$-22.58M
Low Forecast$-109.05M$-84.07M$-46.12M$-45.64M$-28.82M$-22.58M
Surprise %-42.08%-29.87%-8.47%---

PLSE Forecast FAQ

Is Pulse Biosciences stock a buy?

Pulse Biosciences stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Pulse Biosciences is a favorable investment for most analysts.

What is Pulse Biosciences's price target?

Pulse Biosciences's price target, set by 4 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $14.71.

How does Pulse Biosciences stock forecast compare to its benchmarks?

Pulse Biosciences's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (19.91%) and underperforming the medical instruments & supplies stocks industry (23.19%).

What is the breakdown of analyst ratings for Pulse Biosciences over the past three months?

  • July 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • October 2024: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is Pulse Biosciences’s EPS forecast?

Pulse Biosciences's average annual EPS forecast for its fiscal year ending in December 2024 is $-0.95, marking a 7.95% increase from the reported $-0.88 in 2023. Estimates for the following years are $-0.6 in 2025, and $-0.47 in 2026.

What is Pulse Biosciences’s revenue forecast?

Pulse Biosciences's average annual revenue forecast for its fiscal year ending in December 2024 is $800K, reflecting a 0% decrease from the reported $0 in 2023. The forecast for 2025 is $23.37M, and $34.47M for 2026.

What is Pulse Biosciences’s net income forecast?

Pulse Biosciences's net income forecast for the fiscal year ending in December 2024 stands at $-45.636M, representing an 8.12% increase from the reported $-42.21M in 2023. Projections indicate $-28.823M in 2025, and $-22.578M in 2026.